Status of cardiovascular surgery in Japan between 2017 and 2018: A report based on the Japan Cardiovascular Surgery

Tomonobu Abe1, Hiraku Kumamaru2, Kiyoharu Nakano3

  • 1Division of Cardiovascular Surgery, Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan.

Insights

Heart valve surgery in Japan is increasing, with both surgical aortic valve replacement and transcatheter aortic valve replacement showing upward trends. Benchmark data from 2017-2018 reveals operative mortality rates for various procedures, including TAVR and SAVR.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Interventions
  • Health Database Analysis

Background:

  • Valvular heart disease necessitates surgical intervention.
  • Understanding current trends in cardiac valve surgery is crucial for healthcare planning.
  • The Japan Cardiovascular Surgery Database provides valuable insights into surgical practices.

Purpose of the Study:

  • To present current data on valvular heart surgeries in Japan for 2017-2018.
  • To analyze trends in aortic valve replacement (AVR) from 2013-2018.
  • To report operative mortality rates and minimally invasive procedure data.

Main Methods:

  • Extracted cardiac valve surgery data from the Japan Cardiovascular Surgery Database (2017-2018).
  • Calculated operative mortality rates for AVR, mitral valve repair, and mitral valve replacement (biological/mechanical prostheses).
  • Analyzed trends in AVR and data on minimally invasive procedures and transcatheter aortic valve replacement (TAVR).

Main Results:

  • Surgical aortic valve replacement (SAVR) increased from 26,054 to 28,202 cases (2017-2018), alongside a rise in TAVR.
  • Operative mortality rates: 1.8% (isolated SAVR), 0.9% (isolated mitral valve repair), 8.2% (mitral valve replacement with biological prostheses), 4.6% (mitral valve replacement with mechanical prostheses).
  • Overall mortality: 1.5% (TAVR) vs. 1.8% (SAVR). 30.8% of first-time isolated mitral valve plasty procedures used right thoracotomy, associated with better outcomes but lower risk profiles.

Conclusions:

  • Provided benchmark data for heart valve surgery in Japan for 2017-2018.
  • Highlighted increasing trends in both SAVR and TAVR.
  • Demonstrated varying operative mortality rates across different valve procedures and approaches.
Abstract

Related Concept Videos

Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
9.8K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
175
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
115
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
126
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
166
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
227